Canagliflozin, serum magnesium and cardiovascular outcomes—Analysis from the CANVAS Program

BACKGROUND: Patients with type 2 diabetes (T2D) are predisposed to derangements in serum Magnesium (Mg), which may have implications for cardiometabolic events and outcomes. In clinical trials, participants with T2D randomized to sodium‐glucose co‐transporter 2 (SGLT2) inhibitors have shown mild to...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Endocrinol Diabetes Metab
Main Authors: Wang, Katherine M., Li, JingWei, Bhalla, Vivek, Jardine, Meg J., Neal, Bruce, de Zeeuw, Dick, Fulcher, Greg, Perkovic, Vlado, Mahaffey, Kenneth W., Chang, Tara I.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2021
Assuntos:
Original Research Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8279612/
https://ncbi.nlm.nih.gov/pubmed/34277971
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/edm2.247
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados